Department of Orthopaedic Surgery, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark,
Arch Orthop Trauma Surg. 2014 Mar;134(3):375-82. doi: 10.1007/s00402-013-1906-3. Epub 2013 Dec 12.
Red blood cell (RBC) transfusion is a frequently used treatment in patients admitted with a fractured hip, but the use remains an area of much debate. The aim of this study was to determine preoperative factors associated with the risk of receiving a red blood cell transfusion in hip fracture patients.
The study included 986 consecutive hip fracture patients (aged 60 years or above). The patients were identified from a database of all hip fracture patients admitted to Bispebjerg University Hospital. Data for the database are collected via chart review and data extraction from the hospitals laboratory system, public registries and from the Capital Region Blood Bank Database.
Overall transfusion rate was 58.7 %. The univariate analyses showed that transfusion rate was higher among women (p = 0.004), older patients (p < 0.0001), patients with high ASA scores (p < 0.0001), patients with more severe fractures (p < 0.0001), patients with lower admission haemoglobin levels (p < 0.0001), patients not admitted from own home (p = 0.02) and patients taking aspirin (p = 0.007) or other platelet inhibitors (p = 0.01) on admission. In the multivariate analysis, increasing age, ASA ≥3, being admitted from own home, extracapsular fractures, decreasing admission haemoglobin and use of platelet inhibitors were all significantly associated with the risk of receiving a RBC transfusion.
Several readily available preoperative factors in the form of age, residence, ASA, admission haemoglobin, medication and type of fracture were independently associated with the likelihood of receiving a red blood cell transfusion in patients admitted with a fractured hip.
红细胞(RBC)输血是髋部骨折患者入院后的常用治疗方法,但该治疗方法仍存在诸多争议。本研究旨在确定与髋部骨折患者接受 RBC 输血风险相关的术前因素。
该研究纳入了 986 例连续髋部骨折患者(年龄在 60 岁及以上)。这些患者是从比斯加夫医院所有髋部骨折患者的数据库中确定的。数据库中的数据是通过病历回顾和从医院实验室系统、公共登记处以及首都地区血库数据库中提取数据收集的。
总体输血率为 58.7%。单因素分析显示,女性(p = 0.004)、年龄较大的患者(p < 0.0001)、ASA 评分较高的患者(p < 0.0001)、骨折程度更严重的患者(p < 0.0001)、入院时血红蛋白水平较低的患者(p < 0.0001)、非从自家入院的患者(p = 0.02)以及入院时服用阿司匹林(p = 0.007)或其他血小板抑制剂的患者(p = 0.01)输血率较高。多因素分析显示,年龄增加、ASA ≥3、从自家入院、囊外骨折、入院时血红蛋白降低和使用血小板抑制剂与接受 RBC 输血的风险显著相关。
年龄、住所、ASA、入院时血红蛋白、用药和骨折类型等几种术前因素可独立预测髋部骨折患者接受 RBC 输血的可能性。